4-[5-(4'-methoxyphenyl)-4,5-dihydro-1H-3-pyrazolyl]-2-methylphenol | 934736-10-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-[5-(4'-methoxyphenyl)-4,5-dihydro-1H-3-pyrazolyl]-2-methylphenol
• 英文别名: 4-[5-(4-methoxyphenyl)-4,5-dihydro-1H-3-pyrazolyl]-2-methylphenol；4-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-2-methyl-phenol；4-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-2-methylphenol
• CAS: 934736-10-4
• 化学式: C₁₇H₁₈N₂O₂
• 分子量: 282.342
• InChiKey: YZGAFDAWKNLSCA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  53.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-[5-(4'-methoxyphenyl)-4,5-dihydro-1H-3-pyrazolyl]-2-methylphenol 、 邻甲苯异硫氰酸酯 以 乙醇 为溶剂， 反应 4.0h， 以74%的产率得到5-(4-methoxyphenyl)-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-toluidinomethanethione
  参考文献：
  名称：

  新型吡唑啉衍生物的合成及其对人肺肿瘤细胞系 (A549) 的细胞毒活性

  摘要：

  在本研究中，一系列 5-(-4-(取代)苯基)-3-(4-羟基-3-甲基苯基)-4,5-二氢-1H-1-吡唑基-2-甲苯胺基甲硫酮和合成了 5-(取代)苯基-3-(4-羟基-3-甲基苯基)-4,5-二氢-1H-1-吡唑基-2-甲氧基苯胺基甲硫酮，并针对人肺肿瘤细胞系 (A549 ) 在体外使用 MTT 测定系统。在这些测试中，5-(4-氟苯基)-3-(4-羟基-3-甲基苯基)-4,5-二氢-1H-1-吡唑基-2-甲苯胺基甲硫酮和5-(4-氯苯基)- 3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-methoxy anilino methane thione 对人肺肿瘤细胞系 (A549) 的细胞毒性比其他合成化合物更强。

  DOI：

  10.1002/jccs.200700014
• 作为产物：
  描述：

  1-(4-hydroxy-3-methylphenyl)-3-(4-methoxyphenyl)-2-propen-1-one 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 7.0h， 生成 4-[5-(4'-methoxyphenyl)-4,5-dihydro-1H-3-pyrazolyl]-2-methylphenol
  参考文献：
  名称：

  新型吡唑啉衍生物的合成及其对人肺肿瘤细胞系 (A549) 的细胞毒活性

  摘要：

  在本研究中，一系列 5-(-4-(取代)苯基)-3-(4-羟基-3-甲基苯基)-4,5-二氢-1H-1-吡唑基-2-甲苯胺基甲硫酮和合成了 5-(取代)苯基-3-(4-羟基-3-甲基苯基)-4,5-二氢-1H-1-吡唑基-2-甲氧基苯胺基甲硫酮，并针对人肺肿瘤细胞系 (A549 ) 在体外使用 MTT 测定系统。在这些测试中，5-(4-氟苯基)-3-(4-羟基-3-甲基苯基)-4,5-二氢-1H-1-吡唑基-2-甲苯胺基甲硫酮和5-(4-氯苯基)- 3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-methoxy anilino methane thione 对人肺肿瘤细胞系 (A549) 的细胞毒性比其他合成化合物更强。

  DOI：

  10.1002/jccs.200700014

文献信息

• SOCl<sub>2</sub> catalyzed cyclization of chalcones: Synthesis and spectral studies of some bio-potent <sup>1</sup><i>H</i> pyrazoles
  作者：K. Ranganathan、R. Suresh、G. Vanangamudi、K. Thirumurthy、P. Mayavel、G. Thirunarayanan

  DOI：10.4314/bcse.v28i2.11

  日期：——

  Some aryl-aryl 1H pyrazoles have been synthesised by cyclization of aryl chalcones and hydrazine hydrate in the presence of SOCl2. The yields of the pyrazoles are more than 85%. These pyrazoles are characterized by their physical constants and spectral data. The infrared, NMR spectral group frequencies of these pyrazolines have been correlated with Hammett substituent constants, F and R parameters. From the results of statistical analyses the effects of substituent on the spectral frequencies have been studied. The antimicrobial activities of all synthesised pyrazolines have been studied using Bauer-Kirby method.

  一些芳基-芳基1H吡唑通过在SOCl2存在下对芳香醛和水合肼进行环化合成。吡唑的得率超过85%。这些吡唑通过其物理常数和谱学数据进行了表征。这些吡唑频率的红外和核磁共振（NMR）光谱组频率与Hammett取代基常数、F和R参数相关联。通过统计分析结果，研究了取代基对光谱频率的影响。所有合成的吡唑的抗微生物活性通过Bauer-Kirby方法进行了研究。
• Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives
  作者：Mohamed Ashraf Ali、Mohammad Shaharyar、Anees Ahamed Siddiqui

  DOI：10.1016/j.ejmech.2006.08.004

  日期：2007.2

  In the present investigation, a series of 5+4-(substituted) phenyl)-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-IH-1-pyrazolyl-2-toluidino methane thione and 5-(substituted) phenyl-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-methoxyanilino methane thione were synthesized by the reaction between hydrazine hydrate and chalcones (3a-k) followed by condensation with appropriate aryl isothiocyanate which yielded N-substituted pyrazoline derivatives. Newly synthesized compounds were tested for their in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the synthesized compounds, compound anilino-3-(4-hydroxy-3-methylphenyl)-5-(2,6-dichlorophenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione (6i) was found to be more active agent against M. tuberculosis H37Rv with minimum inhibitory concentration of 0.0034 mu M. (c) 2006 Elsevier Masson SAS. All rights reserved.
• Ali, Mohamed Ashraf; Yar, Mohammad Shahar, Acta poloniae pharmaceutica, 2007, vol. 64, # 2, p. 139 - 146
  作者：Ali, Mohamed Ashraf、Yar, Mohammad Shahar

  DOI：——

  日期：——